Earlier this month, over 80 CEOs and investors gathered in Weybridge for our annual UK CEO and Investor Forum. It was great to see so many faces, old and new, meeting to discuss the latest opportunities and challenges in the sector, including some of our newest BIA members – Vasgen, Calchan and IONTAS.
Some interesting discussions were had on driving value through diversity and corporate culture – something the BIA continues to be interested in hearing members’ views and experience on.
To coincide with the event, the BIA also published a new report with market intelligence firm Evaluate. The report, UK Biotech: a 10 year horizon contains some interesting and useful data sets for the sector, including the headline that this year and last are setting new records in financing for the sector.
The CEO forum provided the chance to discuss the new data, including the argument that the UK biotech funding ecosystem is doing things differently this time around – meaning that the UK financing system for innovative companies is better able to withstand a cyclical change than that in the US.
As always, some captivating discussions and debates from one of our flagship events. Check out some pictures from the forum below.